Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Rasmussen

Showing results (861-870 of 877) with videos related to

Pageof 88
Sort By:
Basic & Clinical Pharmacology & Toxicology|June 14, 2023
Appetite stimulation with cannabis-based medicine and methods for assessment of glomerular filtration in older patients with medical illness: A study protocolR L Nielsen, O Bornaes, I K Storgaard, et al.
Arthritis Care & Research|June 26, 2024
Comparing DAPSA, DAPSA28, and DAS28-CRP in Patients With Psoriatic Arthritis Initiating a First Tumor Necrosis Factor Inhibitor Across Nine European CountriesLouise Linde, Stylianos Georgiadis, Lykke M Ørnbjerg, et al.
European Journal of Cancer (Oxford, England : 1990)|September 24, 2024
Detection of circulating tumor DNA by tumor-informed whole-genome sequencing enables prediction of recurrence in stage III colorectal cancer patientsAmanda Frydendahl, Jesper Nors, Mads H Rasmussen, et al.
The Journal of Rheumatology|January 15, 2024
Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine CareLykke M Ørnbjerg, Kathrine Rugbjerg, Stylianos Georgiadis, et al.
The Lancet. Child & Adolescent Health|July 18, 2024
Oral versus intravenous empirical antibiotics in children and adolescents with uncomplicated bone and joint infections: a nationwide, randomised, controlled, non-inferiority trial in DenmarkAllan Bybeck Nielsen, Mette Holm, Morten S Lindhard, et al.
Rheumatology (Oxford, England)|June 14, 2023
Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registriesLouise Linde, Lykke M Ørnbjerg, Stylianos Georgiadis, et al.
Arthritis Research & Therapy|October 20, 2023
Commonalities and differences in set-up and data collection across European spondyloarthritis registries - results from the EuroSpA collaborationLouise Linde, Lykke M Ørnbjerg, Simon H Rasmussen, et al.
Seminars in Arthritis and Rheumatism|August 19, 2022
Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: Data from the EuroSpA collaborationLykke M Ørnbjerg, Louise Linde, Stylianos Georgiadis, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2024
TNM 8 staging system beyond p16: Double HPV/p16 status is superior to p16 alone in predicting outcome in oropharyngeal squamous cell carcinomaChristian von Buchwald, Kathrine Kronberg Jakobsen, Amanda-Louise Fenger Carlander, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2021
Comparative genomics provides insights into the aquatic adaptations of mammalsYuan Yuan, Yaolei Zhang, Peijun Zhang, et al.
Pageof 88

Showing results (861-870 of 877) with videos related to

Sort By:
Pageof 88
Basic & Clinical Pharmacology & Toxicology|June 14, 2023
Appetite stimulation with cannabis-based medicine and methods for assessment of glomerular filtration in older patients with medical illness: A study protocolR L Nielsen, O Bornaes, I K Storgaard, et al.
Arthritis Care & Research|June 26, 2024
Comparing DAPSA, DAPSA28, and DAS28-CRP in Patients With Psoriatic Arthritis Initiating a First Tumor Necrosis Factor Inhibitor Across Nine European CountriesLouise Linde, Stylianos Georgiadis, Lykke M Ørnbjerg, et al.
European Journal of Cancer (Oxford, England : 1990)|September 24, 2024
Detection of circulating tumor DNA by tumor-informed whole-genome sequencing enables prediction of recurrence in stage III colorectal cancer patientsAmanda Frydendahl, Jesper Nors, Mads H Rasmussen, et al.
The Journal of Rheumatology|January 15, 2024
Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine CareLykke M Ørnbjerg, Kathrine Rugbjerg, Stylianos Georgiadis, et al.
The Lancet. Child & Adolescent Health|July 18, 2024
Oral versus intravenous empirical antibiotics in children and adolescents with uncomplicated bone and joint infections: a nationwide, randomised, controlled, non-inferiority trial in DenmarkAllan Bybeck Nielsen, Mette Holm, Morten S Lindhard, et al.
Rheumatology (Oxford, England)|June 14, 2023
Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registriesLouise Linde, Lykke M Ørnbjerg, Stylianos Georgiadis, et al.
Arthritis Research & Therapy|October 20, 2023
Commonalities and differences in set-up and data collection across European spondyloarthritis registries - results from the EuroSpA collaborationLouise Linde, Lykke M Ørnbjerg, Simon H Rasmussen, et al.
Seminars in Arthritis and Rheumatism|August 19, 2022
Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: Data from the EuroSpA collaborationLykke M Ørnbjerg, Louise Linde, Stylianos Georgiadis, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2024
TNM 8 staging system beyond p16: Double HPV/p16 status is superior to p16 alone in predicting outcome in oropharyngeal squamous cell carcinomaChristian von Buchwald, Kathrine Kronberg Jakobsen, Amanda-Louise Fenger Carlander, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2021
Comparative genomics provides insights into the aquatic adaptations of mammalsYuan Yuan, Yaolei Zhang, Peijun Zhang, et al.
Pageof 88